The main etiological factor of cervical intraepithelial neoplasia (CIN) and cervical
cancer is persistent infection with oncogenic types of human papillomavirus (HPV).
Most HPV infections regress spontaneously, while progression to high-grade
lesions usually takes several years. We describe the case of a 24-year-old woman,
unvaccinated against HPV, who had a very rapid progression of HPV16 infection —
from a normal cervical cytology result to histologically confirmed CIN3 within nine
months. The patient presented no clinical symptoms and regularly attended cervical
cancer screening, i.e., cytology. A Pap smear performed in December 2022 revealed
no signs of dysplasia, but nine months later, an LBC cytology test revealed ASC-H
with suspected HSIL, and HPV DNA testing confirmed HPV16 infection. A
Colposcopy identified suspicious areas and biopsies confirmed CIN3.
Histopathology after the first Loop Electrosurgical Excision Procedure (LEEP)
showed CIN3 with positive margins. After the first LEEP procedure, the patient
started a course of Gardasil-9 vaccinations. Because positive margins persisted, the
gynecologist repeated the LEEP twice. The second procedure revealed CIN2 with a
positive surgical margin, while the third showed the absence of intraepithelial
neoplasia. In April 2025, a control LBC cytology test showed no neoplastic changes,
and an HPV test result was negative. This case is remarkable due to the patient's
age and rapid the HPV16 progression. The case emphasizes the role of molecular
biomarkers in risk assessment and the importance of HPV vaccination in primary
prevention.
Keywords: cervical intraepithelial neoplasia; human papillomavirus type 16;
cervical screening; loop electrosurgical excision procedure; surgical margins
